$7.54 +0.11 (%) Halozyme Therapeutics Inc - NASDAQ

Feb. 12, 2016 | 04:00 PM

Partner Headlines

  1. Benzinga's Top Initiations

    Benzinga | Feb. 1, 2016 | 09:52AM EST
  2. Halozyme Confirms $5 Million Milestone Payment From AbbVie

    Benzinga | Jan. 21, 2016 | 14:54PM EST
  3. Mid-Morning Market Update: Markets Down; JPMorgan Beats Q4 Expectations

    Benzinga | Jan. 14, 2016 | 10:06AM EST
  4. Mid-Afternoon Market Update: Dow Tumbles Over 300 Points; Cyberark Shares Gain Following Merger Chatter

    Benzinga | Jan. 13, 2016 | 15:28PM EST
  5. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 4, 2015 | 08:35AM EST
  6. Benzinga's Top Initiations

    Benzinga | Nov. 18, 2015 | 09:34AM EST
  7. Halozyme To Open New San Francisco Office, Expects To Recruit Talent To Help Commercialize New PEGPH20 Drug

    Benzinga | Nov. 17, 2015 | 17:01PM EST
  8. 3 Midsize Drug Stocks Moving On Q3 Reports

    IBD | Nov. 10, 2015 | 13:34PM EST
  9. First Patient Dosed in Clinical Trial of Halozyme Investigational Drug PEGPH20 in Combination With Merck Immuno-oncology Drug KEYTRUDA

    Benzinga | Nov. 5, 2015 | 08:37AM EST
  10. Jim Cramer Advises His Viewers On Halozyme Therapeutics, CF Industries And Tower International

    Benzinga | Aug. 13, 2015 | 06:34AM EST
  11. US Stock Futures Edge Lower Ahead Of Consumer Sentiment Report

    Benzinga | Jul. 31, 2015 | 07:39AM EST
  12. Eisai, Halozyme Anounce Collaboration to Investigate Eribulin and Pegph20 in Advanced Breast Cancer

    Benzinga | Jul. 31, 2015 | 04:19AM EST
  13. Halozyme Stock Hits New High On AbbVie Collaboration

    IBD | Jun. 3, 2015 | 15:28PM EST
  14. New Drug Could Transform Pancreatic Cancer Treatment

    Benzinga | May. 18, 2015 | 14:16PM EST
  15. Halozyme Therapeutics Beats Q4 Views; Outlook Shy Of Consensus

    Benzinga | Mar. 2, 2015 | 18:59PM EST
  16. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  17. Benzinga's Volume Movers

    Benzinga | Jan. 8, 2015 | 10:33AM EST
  18. UPDATE: MLV & Co Raises PT On Halozyme Therapeutics On Promising Start To 2015

    Benzinga | Jan. 8, 2015 | 09:36AM EST
  19. Halozyme Closes In On A Breakout: A Technical Analysis

    Benzinga | Jan. 7, 2015 | 14:31PM EST
  20. What Investors Are Looking for After Seeing Unusual Options Activity In Halozyme

    Benzinga | Jan. 6, 2015 | 12:15PM EST
  21. Benzinga's Top Initiations

    Benzinga | Dec. 24, 2014 | 09:08AM EST
  22. MLV & Co Initiates Halozyme Therapeutics With Buy

    Benzinga | Dec. 24, 2014 | 07:11AM EST
  23. US Stock Futures Edge Higher; Jobless Claims Data In Focus

    Benzinga | Dec. 24, 2014 | 07:03AM EST
  24. Halozyme to Present Preclinical Data on PEGPH20 at SABCS

    Benzinga | Dec. 12, 2014 | 08:03AM EST
  25. Halozyme Announces Presentations Of Preclinical Data At The San Antonio Breast Cancer Symposium Annual Meeting

    Benzinga | Dec. 12, 2014 | 08:03AM EST
  26. Top 10 Biggest New Video Game IP Launches

    Benzinga | Nov. 30, 2014 | 13:04PM EST
  27. Halozyme Therapeutics Plummets On Q3 Losses

    Benzinga | Nov. 10, 2014 | 17:19PM EST
  28. Earnings Scheduled For November 10, 2014

    Benzinga | Nov. 10, 2014 | 05:36AM EST
  29. Insider Buys at Halozyme Look to Improve Stock Outlook

    GuruFocus | Sep. 18, 2014 | 17:49PM EST
  30. Halozyme Announces SWOG Will Resume Clinical Trial of PEGPH20 In Combo with Modified FOLFIRINOX for Advanced Pancreatic Cancer

    Benzinga | Sep. 18, 2014 | 09:04AM EST
  31. Morning Market Movers

    Benzinga | Sep. 15, 2014 | 09:42AM EST
  32. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 15, 2014 | 08:06AM EST
  33. How Can Mattel, Inc. And Other Toymakers Beat Lego?

    Benzinga | Sep. 8, 2014 | 13:23PM EST
  34. Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation

    Benzinga | Sep. 3, 2014 | 08:35AM EST
  35. Intercept Pharma Soars On Positive Liver Drug Data

    IBD | Aug. 11, 2014 | 22:20PM EST
  36. Halozyme Therapeutics Receives Favorable FDA Decision

    Benzinga | Jul. 31, 2014 | 14:45PM EST
  37. Halozyme Announces Resumption of Patient Enrollment, Dosing in PEGPH20 Clinical Trial

    Benzinga | Jul. 22, 2014 | 09:02AM EST
  38. Benzinga's Top Initiations

    Benzinga | Jul. 11, 2014 | 09:18AM EST
  39. JP Morgan Initiates Halozyme Therapeutics With Outperform

    Benzinga | Jul. 11, 2014 | 07:54AM EST
  40. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 25, 2014 | 08:11AM EST
  41. Mid-Day Market Update: US Stocks Surge; PVH Shares Slip On Downbeat Results

    Benzinga | Jun. 5, 2014 | 14:52PM EST
  42. Shares Of Halozyme Up 14% Following FDA Removal Of Hold On PEGPH20

    Benzinga | Jun. 5, 2014 | 11:29AM EST
  43. Morning Market Movers

    Benzinga | Jun. 5, 2014 | 09:40AM EST
  44. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 5, 2014 | 08:10AM EST
  45. Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth Arden Shares Remain Down

    Benzinga | May. 13, 2014 | 15:44PM EST
  46. Mid-Day Movers: GORO, HALO, COCO, UEC, EVDY Moving Higher; RDEN, CALL, DXPE, FTEK Lower

    Benzinga | May. 13, 2014 | 15:38PM EST
  47. Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises Shares Slip

    Benzinga | May. 13, 2014 | 12:40PM EST
  48. Mid-Morning Market Update: Markets Gain; Elizabeth Arden To Explore Strategic Alternatives

    Benzinga | May. 13, 2014 | 10:28AM EST
  49. Morning Market Movers

    Benzinga | May. 13, 2014 | 09:38AM EST
  50. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 13, 2014 | 08:06AM EST
Trading Center